AtriCure (ATRC) Cash from Operations (2010 - 2026)

AtriCure (ATRC) has reported Cash from Operations for 17 consecutive years, with $22.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Operations rose 2.66% year-over-year to $22.2 million in Q2 2026; TTM through Jun 2026 was $64.9 million, a 78.25% increase from a year earlier, with the FY2025 full-year figure at $57.3 million, up 369.8% from the prior year.
• Cash from Operations was $22.2 million for Q2 2026 at AtriCure, up from -$4.0 million in the prior quarter.
• Over five years, Cash from Operations peaked at $26.7 million in Q3 2025 and troughed at -$24.6 million in Q1 2022.
• A 5-year average of $3.9 million and a median of $3.5 million in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations tumbled 668.97% in 2022 and jumped 8660.87% in 2023, its largest moves.
• Over 5 years, Cash from Operations stood at $46000.0 in 2022, then jumped by 8660.87% to $4.0 million in 2023, then jumped by 44.81% to $5.8 million in 2024, then jumped by 243.16% to $20.0 million in 2025, then advanced by 10.81% to $22.2 million in 2026.
• The last three Cash from Operations figures came in at $22.2 million (Q2 2026), -$4.0 million (Q1 2026), and $20.0 million (Q4 2025), per Business Quant data.